American Association for Cancer Research
Browse

sorry, we can't preview this file

crc-22-0438-s01.doc (32 kB)

Table TS1 from Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors

Download (32 kB)
journal contribution
posted on 2023-04-04, 14:23 authored by Boyang Sun, Tian Qiu, Xiaoling Zeng, Jianchun Duan, Hua Bai, Jiachen Xu, Jin Li, Junling Li, Xuezhi Hao, Yutao Liu, Lin Lin, Hongyu Wang, Xin Zhang, Jia Zhong, Jie Wang, Jianming Ying, Zhijie Wang

Clinicopathologic characteristics of patients in cohort 3.

Funding

MOST | National Key Research and Development Program of China (NKPs)

National Natural Science Foundation of China (NSFC)

Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)

History

ARTICLE ABSTRACT

In this study, we established a methodology to differentiate polysomy from normal copy numbers and amplification using NGS. Moreover, this study suggests that it is critical to discriminate MET polysomy from amplification, for the former may dilute the clinical benefit of MET inhibitors.

Usage metrics

    Cancer Research Communications

    Categories

    Keywords

    Lung CancerLiquid BiopsyPrecision MedicineDrug Targets

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC